Jinghui Du

Title: Innovations by Jinghui Du in Drug Modification

Introduction

Jinghui Du is a notable inventor based in Tianjin, China. He has made significant contributions to the field of drug modification through his innovative research and development. His work focuses on enhancing the efficacy and bioavailability of drugs, particularly in the context of cancer treatment.

Latest Patents

Jinghui Du holds a patent for a linker compound, polyethylene glycol-linker conjugate, and derivative thereof, as well as a polyethylene glycol-linker-drug conjugate. This patent discloses a linker compound that can be used to modify drugs, making the modification process simple and efficient. The high reaction yield and wide application range of the modified drugs are significant advantages. These modified drugs are designed to gradually degrade in vivo, allowing them to remain at the lesion site for extended periods. This approach achieves sustained and controlled release, reduces the frequency of administration, and greatly improves the bioavailability of the drug, enhancing patient compliance.

Career Highlights

Jinghui Du is associated with Jenkem Technology Co., Ltd. in Tianjin. His work at this company has been pivotal in advancing drug modification technologies. His innovative approaches have garnered attention in the pharmaceutical industry, particularly for their potential applications in cancer therapy.

Collaborations

Jinghui Du collaborates with esteemed colleagues such as Zewang Feng and Qingbin Wang. Their combined expertise contributes to the success of their projects and enhances the research output of their team.

Conclusion

Jinghui Du's contributions to drug modification represent a significant advancement in pharmaceutical science. His innovative patent and collaborative efforts are paving the way for improved treatment options for patients.